Metraipolis › archive › dc_f2225213b42e

HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study — Europe PMC PMID:41575919

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41575919
DOI
10.1371/journal.pone.0334634
License (as archived)
CC0-1.0
Archived
2026-10-06T08:26:44.287Z
SHA-256 of the archived text
88ace3d2b547a5a7a62413b41df6f0cff43bf1354b6d2d97ea53fdcce16cb760
Stable URL of this page
https://metraipolis.com/documento/dc_f2225213b42e

How to cite

HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study — Europe PMC PMID:41575919 — Europe PMC (en), https://europepmc.org/article/MED/41575919 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f2225213b42e (Metraipolis archive dc_f2225213b42e, sha256 88ace3d2b547a5a7a62413b41df6f0cff43bf1354b6d2d97ea53fdcce16cb760)
BibTeX
@misc{dcf2225213b42e,
  title = {HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study — Europe PMC PMID:41575919},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41575919},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f2225213b42e; sha256 88ace3d2b547a5a7a62413b41df6f0cff43bf1354b6d2d97ea53fdcce16cb760},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/41575919. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

G6PD deficiency (G6PD-D) variants are associated with lower hemoglobin A1c (HbA1c) concentrations, raising concerns about the diagnostic efficacy of HbA1c for abnormal glucose tolerance (Abnl-GT) in Africans, in whom risk of G6PD-D and Abnl-GT is high. G6PD-D is assessed using genotyping or an enzymatic assay, but because G6PD-D is X-linked, the enzymatic assay is necessary for determining status for women heterozygous for deficiency variants. We assessed: 1) ability of HbA1c to detect Abnl-GT by G6PD-D; 2) concordance of genotyping and enzymatic assay for G6PD-D in sub-Saharan Africans living in the US. 534 participants of the Africans in America study were included, with HbA1c ranging from 3.1-11.3%. Abnl-GT determined by HbA1c (≥5.7%) was compared to the diagnostic standard, the oral glucose tolerance test (fasting glucose≥100 mg/dL and/or 2h glucose≥140 mg/dL). G6PD-D status was determined by genotype (n = 263), enzymatic assay (n = 83), or both (n = 188). G6PD-D could not be determined for 13 women heterozygotes with only genotype data. In the remaining participants, HbA1c was 0.9% lower among those with G6PD-D (4.6 ± 0.5; range 3.1-5.6) compared to those with normal G6PD activity (5.5 ± 0.6; range 4.2-11.3; P < 0.001). Glucose concentrations did not differ between groups. HbA1c sensitivity and specificity for Abnl-GT were 0% (0/17) and 100% (37/37) among those with G6PD-D, and 50% (98/195) and 80% (217/272) among those with normal activity. After excluding women heterozygotes, concordance for G6PD-D detection by genotype and the enzymatic assay was 100%. G6PD-D was associated with ~0.9% lower HbA1c in this study, leading to a failure of HbA1c to identify Abnl-GT in these participants. Such a dramatic difference in a screening tool could have consequences in practice, including late diagnosis, undertreatment, and increased complications among those with G6PD-D. Additionally, the results for the enzymatic assay were perfectly concordant with the genotype results for G6PD-D. However, as genotype alone cannot predict G6PD-D in heterozygous women, the enzymatic assay was more informative.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2026 (prima pubblicazione 2026-01-23).
Identificativi: PMID 41575919 · PMCID PMC12829870 · DOI 10.1371/journal.pone.0334634.
Descrittori MeSH principali: Glucosephosphate Dehydrogenase Deficiency; Glucose Intolerance; Glycated Hemoglobin.
Pagina: https://europepmc.org/article/MED/41575919 — https://doi.org/10.1371/journal.pone.0334634. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T08:18:50.386Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.